Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
 Index 
 Full text 
Verbatim report of proceedings
Tuesday, 14 February 2012 - Strasbourg OJ edition

Explanations of vote
MPphoto
 		 

Text tabled : A7-0031/2012

  Andreas Mölzer (NI), in writing. – (DE) Mass immunisation against bluetongue can help to reduce clinical illnesses and losses, impede the spread of the disease and facilitate the safe handling of live animals. Given the varying risks of catching the disease, which are different for each region, mandatory inoculation is questionable on cost grounds. The risk of catching this disease seems to be higher in southern and western regions of the EU than in the north and east. Furthermore, morbidity and mortality also depend on a number of factors. In view of these considerations, I abstained from the vote.

 
Legal notice - Privacy policy